טוען...
Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin
The expansion of regulatory T cells (T(reg)) controls inflammation in children with acute Kawasaki disease (KD). Blockade of tumour necrosis factor (TNF)-α is an emerging therapy for KD patients with refractory inflammation, but there is concern that this therapy could impede the host immune regulat...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Blackwell Science Inc
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3826300/ https://ncbi.nlm.nih.gov/pubmed/23901839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12182 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|